Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 4 of 4 entries
Sorted by: Best Match Show Resources per page
Expanding the Diversity of Imaging-Based RNAi Screen Applications Using Cell Spot Microarrays.

Microarrays (Basel, Switzerland)

Rantala JK, Kwon S, Korkola J, Gray JW.
PMID: 27605183
Microarrays (Basel). 2013 Apr 11;2(2):97-114. doi: 10.3390/microarrays2020097.

Over the past decade, great strides have been made in identifying gene aberrations and deregulated pathways that are associated with specific disease states. These association studies guide experimental studies aimed at identifying the aberrant genes and networks that cause...

Cite
Rantala JK, Kwon S, Korkola J, et al. Expanding the Diversity of Imaging-Based RNAi Screen Applications Using Cell Spot Microarrays. Microarrays (Basel). 2013;2(2):97-114doi: 10.3390/microarrays2020097.
Rantala, J. K., Kwon, S., Korkola, J., & Gray, J. W. (2013). Expanding the Diversity of Imaging-Based RNAi Screen Applications Using Cell Spot Microarrays. Microarrays (Basel, Switzerland), 2(2), 97-114. https://doi.org/10.3390/microarrays2020097
Rantala, Juha K, et al. "Expanding the Diversity of Imaging-Based RNAi Screen Applications Using Cell Spot Microarrays." Microarrays (Basel, Switzerland) vol. 2,2 (2013): 97-114. doi: https://doi.org/10.3390/microarrays2020097
Rantala JK, Kwon S, Korkola J, Gray JW. Expanding the Diversity of Imaging-Based RNAi Screen Applications Using Cell Spot Microarrays. Microarrays (Basel). 2013 Apr 11;2(2):97-114. doi: 10.3390/microarrays2020097. PMID: 27605183; PMCID: PMC5003478.
Copy Download .nbib Format: NLM
Magellan: a web based system for the integrated analysis of heterogeneous biological data and annotations; application to DNA copy number and expression data in ovarian cancer.

Cancer informatics

Kingsley CB, Kuo WL, Polikoff D, Berchuck A, Gray JW, Jain AN.
PMID: 19458754
Cancer Inform. 2007 Feb 05;2:10-21.

Recent advances in high throughput biological methods allow researchers to generate enormous amounts of data from a single experiment. In order to extract meaningful conclusions from this tidal wave of data, it will be necessary to develop analytical methods...

Cite
Kingsley CB, Kuo WL, Polikoff D, et al. Magellan: a web based system for the integrated analysis of heterogeneous biological data and annotations; application to DNA copy number and expression data in ovarian cancer. Cancer Inform. 2007;2:10-21
Kingsley, C. B., Kuo, W. L., Polikoff, D., Berchuck, A., Gray, J. W., & Jain, A. N. (2007). Magellan: a web based system for the integrated analysis of heterogeneous biological data and annotations; application to DNA copy number and expression data in ovarian cancer. Cancer informatics, 210-21.
Kingsley, Chris B, et al. "Magellan: a web based system for the integrated analysis of heterogeneous biological data and annotations; application to DNA copy number and expression data in ovarian cancer." Cancer informatics vol. 2 (2007): 10-21.
Kingsley CB, Kuo WL, Polikoff D, Berchuck A, Gray JW, Jain AN. Magellan: a web based system for the integrated analysis of heterogeneous biological data and annotations; application to DNA copy number and expression data in ovarian cancer. Cancer Inform. 2007 Feb 05;2:10-21. PMID: 19458754; PMCID: PMC2675496.
Copy Download .nbib Format: NLM
Label-Free Quantitation and Mapping of the ErbB2 Tumor Receptor by Multiple Protease Digestion with Data-Dependent (MS1) and Data-Independent (MS2) Acquisitions.

International journal of proteomics

Held JM, Schilling B, D'Souza AK, Srinivasan T, Behring JB, Sorensen DJ, Benz CC, Gibson BW.
PMID: 23710360
Int J Proteomics. 2013;2013:791985. doi: 10.1155/2013/791985. Epub 2013 Apr 04.

The receptor tyrosine kinase ErbB2 is a breast cancer biomarker whose posttranslational modifications (PTMs) are a key indicator of its activation. Quantifying the expression and PTMs of biomarkers such as ErbB2 by selected reaction monitoring (SRM) mass spectrometry has...

Cite
Held JM, Schilling B, D'Souza AK, et al. Label-Free Quantitation and Mapping of the ErbB2 Tumor Receptor by Multiple Protease Digestion with Data-Dependent (MS1) and Data-Independent (MS2) Acquisitions. Int J Proteomics. 2013;2013:791985doi: 10.1155/2013/791985.
Held, J. M., Schilling, B., D'Souza, A. K., Srinivasan, T., Behring, J. B., Sorensen, D. J., Benz, C. C., & Gibson, B. W. (2013). Label-Free Quantitation and Mapping of the ErbB2 Tumor Receptor by Multiple Protease Digestion with Data-Dependent (MS1) and Data-Independent (MS2) Acquisitions. International journal of proteomics, 2013791985. https://doi.org/10.1155/2013/791985
Held, Jason M, et al. "Label-Free Quantitation and Mapping of the ErbB2 Tumor Receptor by Multiple Protease Digestion with Data-Dependent (MS1) and Data-Independent (MS2) Acquisitions." International journal of proteomics vol. 2013 (2013): 791985. doi: https://doi.org/10.1155/2013/791985
Held JM, Schilling B, D'Souza AK, Srinivasan T, Behring JB, Sorensen DJ, Benz CC, Gibson BW. Label-Free Quantitation and Mapping of the ErbB2 Tumor Receptor by Multiple Protease Digestion with Data-Dependent (MS1) and Data-Independent (MS2) Acquisitions. Int J Proteomics. 2013;2013:791985. doi: 10.1155/2013/791985. Epub 2013 Apr 04. PMID: 23710360; PMCID: PMC3654371.
Copy Download .nbib Format: NLM
High quality copy number and genotype data from FFPE samples using Molecular Inversion Probe (MIP) microarrays.

BMC medical genomics

Wang Y, Carlton VE, Karlin-Neumann G, Sapolsky R, Zhang L, Moorhead M, Wang ZC, Richardson AL, Warren R, Walther A, Bondy M, Sahin A, Krahe R, Tuna M, Thompson PA, Spellman PT, Gray JW, Mills GB, Faham M.
PMID: 19228381
BMC Med Genomics. 2009 Feb 19;2:8. doi: 10.1186/1755-8794-2-8.

BACKGROUND: A major challenge facing DNA copy number (CN) studies of tumors is that most banked samples with extensive clinical follow-up information are Formalin-Fixed Paraffin Embedded (FFPE). DNA from FFPE samples generally underperforms or suffers high failure rates compared...

Cite
Wang Y, Carlton VE, Karlin-Neumann G, et al. High quality copy number and genotype data from FFPE samples using Molecular Inversion Probe (MIP) microarrays. BMC Med Genomics. 2009;2:8doi: 10.1186/1755-8794-2-8.
Wang, Y., Carlton, V. E., Karlin-Neumann, G., Sapolsky, R., Zhang, L., Moorhead, M., Wang, Z. C., Richardson, A. L., Warren, R., Walther, A., Bondy, M., Sahin, A., Krahe, R., Tuna, M., Thompson, P. A., Spellman, P. T., Gray, J. W., Mills, G. B., & Faham, M. (2009). High quality copy number and genotype data from FFPE samples using Molecular Inversion Probe (MIP) microarrays. BMC medical genomics, 28. https://doi.org/10.1186/1755-8794-2-8
Wang, Yuker, et al. "High quality copy number and genotype data from FFPE samples using Molecular Inversion Probe (MIP) microarrays." BMC medical genomics vol. 2 (2009): 8. doi: https://doi.org/10.1186/1755-8794-2-8
Wang Y, Carlton VE, Karlin-Neumann G, Sapolsky R, Zhang L, Moorhead M, Wang ZC, Richardson AL, Warren R, Walther A, Bondy M, Sahin A, Krahe R, Tuna M, Thompson PA, Spellman PT, Gray JW, Mills GB, Faham M. High quality copy number and genotype data from FFPE samples using Molecular Inversion Probe (MIP) microarrays. BMC Med Genomics. 2009 Feb 19;2:8. doi: 10.1186/1755-8794-2-8. PMID: 19228381; PMCID: PMC2649948.
Copy Download .nbib Format: NLM
Showing 1 to 4 of 4 entries